Table 2 Characteristics of patients included in the western blot study
From: Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer’s disease brain
Variables | Controls (n = 6) | AD (n = 10) | P-value |
|---|---|---|---|
Age at death (years) | |||
Median [IQR] | 74.0 [70.5–80.0] | 81.0 [78.0–85.0] | 0.032 |
Range | 67.0–86.0 | 62.0–89.0 | |
Female gender, n (%) | 2 (33.3) | 5 (55.5) | NS |
Post mosterm interval | |||
Median [IQR] | 17.5 [12.0–22.0] | 8 [7.5–23.0] | NS |
Range | 4.0–36.0 | 6.0–50.0 | |
Missing (n) | 1 | 0 | |
“A” Thal - n of patients (%) | < 0.001 | ||
3 (4 and 5) | 0 (0) | 8 (80) | |
2 (3) | 0 (0) | 1 (10) | |
1 (1 and 2) | 1 (16.7) | 1 (10) | |
0 (None) | 5 (83.3) | 0 (0) | |
“B” Braak Stage - n of patients (%) | < 0.001 | ||
3 (V and VI) | 0 (0) | 10 (100) | |
2 (III and IV) | 0 (0) | 0 (0) | |
1 (I and II) | 5 (83.3) | 0 (0) | |
0 (None) | 1 (16.7) | 0 (0) | |